Cargando…

Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma

Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for those patients with unresectable tumors. Neoadjuvant therapy is not part of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nava, Carla Fernanda, Scheffel, Rafael Selbach, Cristo, Ana Patrícia, Ferreira, Carla Vaz, Weber, Shana, Zanella, André Borsatto, Paixão, Francisco Costa, Migliavaca, Alceu, Guimarães, José Ricardo, Graudenz, Marcia Silveira, Dora, José Miguel, Maia, Ana Luiza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817485/ https://www.ncbi.nlm.nih.gov/pubmed/31695679 http://dx.doi.org/10.3389/fendo.2019.00712

Ejemplares similares

Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort
por: Nava, Carla Fernanda, et al.
Publicado: (2019)

The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma
por: Scheffel, Rafael Selbach, et al.
Publicado: (2020)

Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
por: Zanella, André Borsatto, et al.
Publicado: (2022)

Intraoperative frozen section performance for thyroid cancer diagnosis
por: Goemann, Iuri Martin, et al.
Publicado: (2022)

T3 therapy for hypothyroidism: choosing wisely still requires careful bench to bedside translation
por: Dora, Jose Miguel, et al.
Publicado: (2021)

Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil
por: Silveira, Vitor Bock, et al.
Publicado: (2022)

Patterns of radioiodine use for differentiated thyroid carcinoma in Brazil: insights and a call for action from a 20-year database
por: Schwengber, Wallace Klein, et al.
Publicado: (2020)

The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer
por: Scheffel, Rafael Selbach, et al.
Publicado: (2019)

Increasing diagnostic effectiveness of thyroid nodule evaluation by implementation of cell block preparation in routine US-FNA analysis
por: de Cristo, Ana Patrícia, et al.
Publicado: (2016)

Increasing the Radioiodine Dose Does Not Improve Cure Rates in Severe Graves' Hyperthyroidism: A Clinical Trial with Historical Control
por: Dora, Jose Miguel, et al.
Publicado: (2013)

Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study
por: Golbert, Lenara, et al.
Publicado: (2017)

Invasive fungal infections in endogenous Cushing's syndrome
por: Scheffel, Rafael Selbach, et al.
Publicado: (2010)

Daily Management of Patients on Multikinase Inhibitors’ Treatment
por: Colombo, Carla, et al.
Publicado: (2022)

Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
por: Reinert, Tomás, et al.
Publicado: (2016)

Predictors of Response and Survival to Multikinase Inhibitors in Radioiodine Resistant Differentiated Thyroid Cancer
por: Feola, Tiziana, et al.
Publicado: (2021)

Transarterial chemoembolization with or without multikinase inhibitors for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials
por: Dong, Han, et al.
Publicado: (2023)

Multikinase Inhibitor Treatment in Thyroid Cancer
por: Ancker, Ole Vincent, et al.
Publicado: (2019)

Rare complications of multikinase inhibitor treatment
por: Pitoia, Fabián, et al.
Publicado: (2018)

Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study
por: Schwengber, Wallace Klein, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer
por: Goemann, Iuri Martin, et al.
Publicado: (2020)

Advanced medullary thyroid cancer: pathophysiology and management
por: Ferreira, Carla Vaz, et al.
Publicado: (2013)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

Inositol polyphosphate multikinase signaling in the regulation of metabolism
por: Lee, Joo-Young, et al.
Publicado: (2012)

Multikinase inhibitors use in differentiated thyroid carcinoma
por: Jasim, Sina, et al.
Publicado: (2014)

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Emerging role of multikinase inhibitors for refractory thyroid cancer
por: Perez, Cesar A, et al.
Publicado: (2012)

Exploring Selectivity of Multikinase Inhibitors across the Human Kinome
por: Miljković, Filip, et al.
Publicado: (2018)

Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib
por: Lin, Tong, et al.
Publicado: (2017)

Targeting RET-rearranged lung cancers with multikinase inhibitors
por: Sabari, Joshua K., et al.
Publicado: (2017)

Timing of multikinase inhibitor initiation in differentiated thyroid cancer
por: Brose, Marcia S, et al.
Publicado: (2017)

Gastrointestinal Tract Homeostasis: The Role of the Inositol Polyphosphate Multikinase
por: Saiardi, Adolfo
Publicado: (2022)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012)

Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal
por: Joshi, Amit, et al.
Publicado: (2015)

Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors
por: Cirello, Valentina, et al.
Publicado: (2016)

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
por: Konecny, G E, et al.
Publicado: (2009)

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
por: Stjepanovic, Neda, et al.
Publicado: (2014)

Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012)

Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2014)

Clinically relevant drug interactions with multikinase inhibitors: a review
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7107gkkc105oebph63vrk0pgt2